Are Urine Biomarkers Ready for Prime Time in Detecting Early Ovarian Cancer?
Can Gene Fusions Alter Transcriptional Regulation in High-Grade Ovarian Cancer?
HOPA 2019: Intraperitoneal vs. Dose-Dense Chemotherapy in Stage III Ovarian Cancer
AACR 2019: Can Use of Oral Contraceptives Protect Against Aggressive Ovarian Cancer?
Genetic Testing in Breast and Ovarian Cancer
Improving Detection of Ovarian Cancer With the CA125 Biomarker
Is Female Infertility Associated With a Higher Risk of Cancer?
Treatment With Avelumab in Resistant Ovarian Cancer
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer
Consensus or Controversy: Management of initial relapse of ovarian cancer — Eight investigators weigh in on their current approach based on genomic profiling
Oncology Grand Rounds: PARP Inhibitors in Ovarian Cancer
Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Ovarian Cancer
University of Colorado Cancer Center
The Ovarian Cancer Consortium for Long-Term Survival
Stanford Cancer Institute
NCCN Guidelines for Patients®
American Cancer Society
Ovations for the Cure of Ovarian Cancer